fenoldopam has been researched along with Acute Kidney Failure in 78 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among patients with acute kidney injury after cardiac surgery, fenoldopam infusion, compared with placebo, did not reduce the need for renal replacement therapy or risk of 30-day mortality but was associated with an increased rate of hypotension." | 9.19 | Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. ( Alvaro, G; Amantea, B; Baldassarri, R; Bellomo, R; Bove, T; Calabrò, MG; Camata, A; Caramelli, F; Cariello, C; Comis, M; Conte, M; Dal Checco, E; Faita, L; Frontini, M; Galdieri, N; Guarracino, F; Landoni, G; Lembo, R; Maglioni, E; Martinez, B; Pala, G; Pappalardo, F; Pasero, DC; Paternoster, G; Persi, B; Pinelli, F; Pisano, A; Renzini, M; Saleh, O; Scandroglio, AM; Verdecchia, C; Zangrillo, A; Zucchetti, MC, 2014) |
| "We examined all studies regarding the role of Fenoldopam mesylate in Acute Kidney Injury (AKI); particularly, those involving post-surgical patients, intensive care unit patients and contrastinduced nephropathy." | 9.01 | Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury. ( Busca, A; Di Daniele, N; Ferrannini, M; Gola, C; Marrone, G; Noce, A; Rovella, V, 2019) |
| "We report two cases of children with severe cardiomyopathy requiring treatment with ventricular assist devices who developed acute kidney injury and were treated with fenoldopam." | 7.74 | Fenoldopam for acute kidney injury in children. ( Andreoli, SP; Knoderer, CA; Leiser, JD; Nailescu, C; Turrentine, MW, 2008) |
| "It was hypothesized that fenoldopam mesylate, a selective dopamine agonist, may preserve renal perfusion and decrease tubular oxygen consumption during states of hypoperfusion, such as hypovolemic shock." | 7.71 | Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs. ( Duggan, PF; Gaffney, E; Halpenny, M; Markos, F; O'Connell, DP; Shorten, GD; Snow, HM, 2001) |
| "Acute renal failure is common in septic patients." | 6.71 | Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. ( Bellomo, R; Bruno, A; Coluzzi, F; Conti, G; De Gaetano, A; Morelli, A; Orecchioni, A; Picchini, U; Pietropaoli, P; Portieri, M; Porzi, P; Ricci, Z; Rocco, M; Ronco, C; Serio, P, 2005) |
| "Fenoldopam is a selective dopamine-1 receptor agonist with renoprotective properties." | 6.52 | Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis. ( Gillies, MA; Honoré, PM; Kakar, V; Ostermann, M; Parker, RJ, 2015) |
| "Among patients with acute kidney injury after cardiac surgery, fenoldopam infusion, compared with placebo, did not reduce the need for renal replacement therapy or risk of 30-day mortality but was associated with an increased rate of hypotension." | 5.19 | Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. ( Alvaro, G; Amantea, B; Baldassarri, R; Bellomo, R; Bove, T; Calabrò, MG; Camata, A; Caramelli, F; Cariello, C; Comis, M; Conte, M; Dal Checco, E; Faita, L; Frontini, M; Galdieri, N; Guarracino, F; Landoni, G; Lembo, R; Maglioni, E; Martinez, B; Pala, G; Pappalardo, F; Pasero, DC; Paternoster, G; Persi, B; Pinelli, F; Pisano, A; Renzini, M; Saleh, O; Scandroglio, AM; Verdecchia, C; Zangrillo, A; Zucchetti, MC, 2014) |
| "We examined all studies regarding the role of Fenoldopam mesylate in Acute Kidney Injury (AKI); particularly, those involving post-surgical patients, intensive care unit patients and contrastinduced nephropathy." | 5.01 | Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury. ( Busca, A; Di Daniele, N; Ferrannini, M; Gola, C; Marrone, G; Noce, A; Rovella, V, 2019) |
| "Because at present no pharmacologic prevention or treatment of acute kidney injury seems to be available, the authors updated a meta-analysis to investigate the effects of fenoldopam in reducing acute kidney injury in patients undergoing cardiac surgery, focusing on randomized placebo-controlled studies only." | 4.88 | Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials. ( Bignami, E; Biondi-Zoccai, GG; Bove, T; Cabrini, L; Covello, RD; Frati, E; Guarracino, F; Landoni, G; Ruggeri, L; Zangrillo, A, 2012) |
| " Two unblinded reviewers selected randomized controlled trials that used fenoldopam in the prevention or treatment of acute kidney injury in postoperative or intensive care patients." | 4.84 | Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. ( Biondi-Zoccai, GG; Bove, T; Calabrò, MG; De Luca, M; Landoni, G; Ranucci, M; Tumlin, JA; Zangrillo, A, 2007) |
| "We report two cases of children with severe cardiomyopathy requiring treatment with ventricular assist devices who developed acute kidney injury and were treated with fenoldopam." | 3.74 | Fenoldopam for acute kidney injury in children. ( Andreoli, SP; Knoderer, CA; Leiser, JD; Nailescu, C; Turrentine, MW, 2008) |
| "1 microg/kg/min of fenoldopam, unilateral renal ischemia (1 hour, left renal artery cross-clamping) followed by 4 hours of reperfusion, and unilateral renal I/R with fenoldopam infusion." | 3.73 | Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure. ( Aravindan, N; Natarajan, M; Shaw, AD, 2006) |
| "We describe the use of fenoldopam to increase urine output in a pediatric patient with sepsis, heart failure, oliguria, and volume overload." | 3.73 | Use of fenoldopam to increase urine output in a patient with renal insufficiency secondary to septic shock: A case report. ( Moffett, BS; Orellana, R, 2006) |
| "It was hypothesized that fenoldopam mesylate, a selective dopamine agonist, may preserve renal perfusion and decrease tubular oxygen consumption during states of hypoperfusion, such as hypovolemic shock." | 3.71 | Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs. ( Duggan, PF; Gaffney, E; Halpenny, M; Markos, F; O'Connell, DP; Shorten, GD; Snow, HM, 2001) |
| "The present studies were conducted to: a) comparatively evaluate the effects of clevidipine, a new dihydropyridine calcium antagonist, and fenoldopam, a dopamine (D-1) receptor agonist on basal renal function, and b) to determine the efficacy of these agents in protecting renal function in an experimental model of ischemia/reperfusion (I/R) induced acute renal failure in rats." | 3.71 | Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats. ( Jandhyala, BS; Stephens, CT, 2002) |
| "Fenoldopam is a short-acting dopamine-1 receptor agonist that might provide renal protection during ischemic stress." | 2.78 | Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial. ( Bonilla, AM; Campbell, SC; Fergany, AF; Gill, IS; Kaouk, JH; Kaple, KM; Mahboobi, R; Mascha, EJ; Novak, SM; O'Hara, JF; Sessler, DI; Ziegman, SA, 2013) |
| "Acute kidney injury is a frequent problem among many critically ill patients, commonly in the context of multiple organ failure and decreased renal perfusion." | 2.76 | Fenoldopam in critically ill patients with early renal dysfunction. A crossover study. ( Barquist, E; Cobas, M; Cudemus, G; De La Pena, M; Paparcuri, G; Varon, A, 2011) |
| "Fenoldopam mesylate is a selective dopamine-1 agonist, with no effect on dopamine-2 and alpha1 receptors, producing a selective renal vasodilation." | 2.72 | A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. ( Ancona, G; Bortone, D; Brienza, N; Bruno, F; Dalfino, L; Faconda, G; Fiore, T; Guagliardi, C; Malcangi, V; Ribezzi, M; Trerotoli, P, 2006) |
| "Fenoldopam prophylaxis was significantly associated with a reduction in acute renal failure incidence (from 22% to 11%, p = 0." | 2.71 | Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. ( Barzaghi, N; Bove, T; Giordano, G; Juliano, G; Locatelli, A; Manzato, A; Melchiorri, C; Ranucci, M; Soro, G; Uslenghi, MF; Vavassori, A, 2004) |
| "Acute renal failure is common in septic patients." | 2.71 | Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. ( Bellomo, R; Bruno, A; Coluzzi, F; Conti, G; De Gaetano, A; Morelli, A; Orecchioni, A; Picchini, U; Pietropaoli, P; Portieri, M; Porzi, P; Ricci, Z; Rocco, M; Ronco, C; Serio, P, 2005) |
| "Fenoldopam mesylate is a dopamine A1 receptor agonist that augments renal plasma flow (RPF) in patients with normotensive and hypertensive conditions." | 2.70 | Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. ( Mathur, VS; Murray, PT; Tumlin, JA; Wang, A, 2002) |
| "Fenoldopam is a new, selective, dopamine-1 receptor agonist that causes both systemic and renal arteriolar vasodilation." | 2.69 | The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. ( Anjum, S; Epstein, M; Fellmann, J; Lambrecht, LJ; Luther, RR; Mathur, VS; McGuire, D; Swan, SK, 1999) |
| "Fenoldopam is a selective dopamine-1 receptor agonist with renoprotective properties." | 2.52 | Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis. ( Gillies, MA; Honoré, PM; Kakar, V; Ostermann, M; Parker, RJ, 2015) |
| "Acute renal failure/acute kidney injury is classified according to the RIFLE criteria where a change from baseline serum creatinine or urine output determines the level of renal dysfunction." | 2.44 | Acute renal failure. ( Kellum, JA; Leblanc, M; Venkataraman, R, 2008) |
| "Dopamine use in acute renal failure (ARF) patients has been considered standard practice for many years." | 2.44 | Current literature questions the routine use of low-dose dopamine. ( Abay, MC; Everts, K; Reyes, JD; Wisser, J, 2007) |
| "Acute renal failure is a common and threatening complication in patients undergoing cardiovascular surgery." | 2.44 | Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. ( Biondi-Zoccai, GG; Bove, T; Calabrò, MG; Fochi, O; Landoni, G; Maj, G; Marino, G; Ranucci, M; Sheiban, I; Tumlin, JA; Zangrillo, A, 2008) |
| "Fenoldopam has no dopamine-2, alpha or beta-adrenergic activity and is 3." | 2.41 | [Fenoldopam: potential clinical applications in heart surgery]. ( Shorten, GD, 2001) |
| "fenoldopam was given during catheter-based coronary procedures." | 1.38 | Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk. ( Hassanin, A; Kirtane, AJ; Leon, MB; Mehran, R; Moses, JW; Talati, S; Weisz, G, 2012) |
| "Patients who developed acute renal injury (defined as serum creatinine doubling or oliguria) after cardiac surgery received a continuous infusion of fenoldopam, 0." | 1.35 | Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery. ( Landoni, G; Lobreglio, R; Roasio, A; Santin, A; Verdecchia, C, 2008) |
| "D." | 1.33 | Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent. ( Finkel, K; Gubert, M; Johnson, T; Samuels, J; Shaw, A, 2005) |
| "Treatment with fenoldopam increased renal blood flow in comparison to that in the control group ( p = 0." | 1.32 | The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping. ( Bird, ET; Cohn, EJ; Harlin, SA; Harre, JG; Hogan, MB; Holmes, GF; Miller, ML; Miller, Q; Peyton, BD; Riley, KD; Taylor, A, 2003) |
| "Fenoldopam is a selective dopamine-receptor agonist with renoprotective properties." | 1.31 | Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients. ( Madyoon, H, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (3.85) | 18.2507 |
| 2000's | 50 (64.10) | 29.6817 |
| 2010's | 25 (32.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Segev, G | 1 |
| Bruchim, Y | 1 |
| Berl, N | 1 |
| Cohen, A | 1 |
| Aroch, I | 1 |
| Sun, H | 1 |
| Xie, Q | 1 |
| Peng, Z | 1 |
| Noce, A | 1 |
| Marrone, G | 1 |
| Rovella, V | 1 |
| Busca, A | 1 |
| Gola, C | 1 |
| Ferrannini, M | 1 |
| Di Daniele, N | 1 |
| Alsabbagh, MM | 1 |
| Asmar, A | 1 |
| Ejaz, NI | 1 |
| Aiyer, RK | 1 |
| Kambhampati, G | 1 |
| Ejaz, AA | 1 |
| Quintavalle, C | 1 |
| Donnarumma, E | 1 |
| Fiore, D | 1 |
| Briguori, C | 1 |
| Condorelli, G | 1 |
| Bove, T | 5 |
| Zangrillo, A | 5 |
| Guarracino, F | 2 |
| Alvaro, G | 1 |
| Persi, B | 1 |
| Maglioni, E | 1 |
| Galdieri, N | 1 |
| Comis, M | 1 |
| Caramelli, F | 1 |
| Pasero, DC | 1 |
| Pala, G | 1 |
| Renzini, M | 1 |
| Conte, M | 1 |
| Paternoster, G | 1 |
| Martinez, B | 1 |
| Pinelli, F | 1 |
| Frontini, M | 1 |
| Zucchetti, MC | 1 |
| Pappalardo, F | 1 |
| Amantea, B | 1 |
| Camata, A | 1 |
| Pisano, A | 1 |
| Verdecchia, C | 2 |
| Dal Checco, E | 1 |
| Cariello, C | 1 |
| Faita, L | 1 |
| Baldassarri, R | 1 |
| Scandroglio, AM | 1 |
| Saleh, O | 1 |
| Lembo, R | 1 |
| Calabrò, MG | 3 |
| Bellomo, R | 2 |
| Landoni, G | 6 |
| Winkelmayer, WC | 1 |
| Finkel, KW | 1 |
| Biancofiore, G | 1 |
| Bindi, ML | 1 |
| Miccoli, M | 1 |
| Cerutti, E | 1 |
| Lavezzo, B | 1 |
| Pucci, L | 1 |
| Bisà, M | 1 |
| Esposito, M | 1 |
| Meacci, L | 1 |
| Mozzo, R | 1 |
| Stratta, C | 1 |
| Penno, G | 1 |
| Baggiani, A | 1 |
| Filipponi, F | 1 |
| Marenzi, G | 1 |
| Paino, R | 1 |
| Liu, Y | 1 |
| Xue, FS | 1 |
| Li, RP | 1 |
| Gillies, MA | 1 |
| Kakar, V | 1 |
| Parker, RJ | 1 |
| Honoré, PM | 1 |
| Ostermann, M | 1 |
| O'Neal, JB | 1 |
| Shaw, AD | 2 |
| Billings, FT | 1 |
| Mas-Font, S | 1 |
| Ros-Martinez, J | 1 |
| Pérez-Calvo, C | 1 |
| Villa-Díaz, P | 1 |
| Aldunate-Calvo, S | 1 |
| Moreno-Clari, E | 1 |
| Bignami, E | 2 |
| Gonfalini, M | 1 |
| Mizzi, A | 1 |
| Kellum, JA | 2 |
| Leblanc, M | 5 |
| Venkataraman, R | 5 |
| Tumlin, JA | 5 |
| Ranucci, M | 4 |
| Brienza, N | 2 |
| Giglio, MT | 1 |
| Marucci, M | 1 |
| Cobas, M | 1 |
| Paparcuri, G | 1 |
| De La Pena, M | 1 |
| Cudemus, G | 1 |
| Barquist, E | 1 |
| Varon, A | 1 |
| Coleman, MD | 1 |
| Shaefi, S | 1 |
| Sladen, RN | 2 |
| Ricci, Z | 2 |
| Luciano, R | 1 |
| Favia, I | 1 |
| Garisto, C | 1 |
| Muraca, M | 1 |
| Morelli, S | 1 |
| Di Chiara, L | 1 |
| Cogo, P | 1 |
| Picardo, S | 1 |
| Nigwekar, SU | 1 |
| Waikar, SS | 1 |
| Biondi-Zoccai, GG | 3 |
| Frati, E | 1 |
| Covello, RD | 1 |
| Cabrini, L | 1 |
| Ruggeri, L | 1 |
| Talati, S | 1 |
| Kirtane, AJ | 1 |
| Hassanin, A | 1 |
| Mehran, R | 3 |
| Leon, MB | 1 |
| Moses, JW | 1 |
| Weisz, G | 2 |
| Arora, P | 1 |
| Kolli, H | 1 |
| Nainani, N | 1 |
| Nader, N | 1 |
| Lohr, J | 1 |
| Caixeta, A | 1 |
| Dogan, O | 1 |
| O'Hara, JF | 1 |
| Mahboobi, R | 1 |
| Novak, SM | 1 |
| Bonilla, AM | 1 |
| Mascha, EJ | 1 |
| Fergany, AF | 1 |
| Campbell, SC | 1 |
| Kaouk, JH | 1 |
| Kaple, KM | 1 |
| Gill, IS | 1 |
| Ziegman, SA | 1 |
| Sessler, DI | 1 |
| Huang, WC | 1 |
| Mathur, VS | 4 |
| Ashby, DT | 1 |
| Kini, AA | 1 |
| Sharma, SK | 1 |
| Madyoon, H | 2 |
| Stone, GW | 1 |
| Lepor, NE | 2 |
| McCullough, PA | 2 |
| Murray, PT | 3 |
| O'Neill, WW | 1 |
| Miller, Q | 1 |
| Peyton, BD | 1 |
| Cohn, EJ | 1 |
| Holmes, GF | 1 |
| Harlin, SA | 1 |
| Bird, ET | 1 |
| Harre, JG | 1 |
| Miller, ML | 1 |
| Riley, KD | 1 |
| Hogan, MB | 1 |
| Taylor, A | 1 |
| Khanna, A | 1 |
| Caporelli, S | 1 |
| Loggi, S | 1 |
| Zompanti, V | 1 |
| Romano, R | 1 |
| Carbonari, L | 1 |
| Alò, F | 1 |
| Antognini, M | 1 |
| Pelaia, P | 1 |
| Asif, A | 2 |
| Epstein, M | 4 |
| Leung, N | 1 |
| Textor, SC | 1 |
| Soro, G | 1 |
| Barzaghi, N | 1 |
| Locatelli, A | 1 |
| Giordano, G | 1 |
| Vavassori, A | 1 |
| Manzato, A | 1 |
| Melchiorri, C | 1 |
| Juliano, G | 1 |
| Uslenghi, MF | 1 |
| Epstein, DL | 1 |
| Kellum, J | 4 |
| Rocca, GD | 1 |
| Pompei, L | 1 |
| Costa, MG | 1 |
| Coccia, C | 1 |
| Scudeller, L | 1 |
| Marco, PD | 1 |
| Monaco, S | 1 |
| Pietropaoli, P | 2 |
| Samuels, J | 1 |
| Finkel, K | 1 |
| Gubert, M | 1 |
| Johnson, T | 1 |
| Shaw, A | 1 |
| Itoh, Y | 1 |
| Yano, T | 1 |
| Sendo, T | 1 |
| Oishi, R | 1 |
| Rezkalla, SH | 1 |
| Morelli, A | 1 |
| Ronco, C | 1 |
| Rocco, M | 1 |
| Conti, G | 1 |
| De Gaetano, A | 1 |
| Picchini, U | 1 |
| Orecchioni, A | 1 |
| Portieri, M | 1 |
| Coluzzi, F | 1 |
| Porzi, P | 1 |
| Serio, P | 1 |
| Bruno, A | 1 |
| Kolarz, M | 1 |
| Sułowicz, W | 1 |
| Goldstein, SL | 1 |
| Chang, AC | 1 |
| Laake, JH | 1 |
| Bugge, JF | 1 |
| Ng, MK | 1 |
| Tremmel, J | 1 |
| Fitzgerald, PJ | 1 |
| Fearon, WF | 1 |
| Malcangi, V | 1 |
| Dalfino, L | 1 |
| Trerotoli, P | 1 |
| Guagliardi, C | 1 |
| Bortone, D | 1 |
| Faconda, G | 1 |
| Ribezzi, M | 1 |
| Ancona, G | 1 |
| Bruno, F | 1 |
| Fiore, T | 1 |
| Aravindan, N | 1 |
| Natarajan, M | 1 |
| Moffett, BS | 1 |
| Orellana, R | 1 |
| De Luca, M | 1 |
| Allie, DE | 1 |
| Hebert, CJ | 1 |
| Walker, CM | 1 |
| Abay, MC | 1 |
| Reyes, JD | 1 |
| Everts, K | 1 |
| Wisser, J | 1 |
| Nicoletta, G | 1 |
| Cascelli, M | 1 |
| Marchesini, L | 1 |
| Tesoro, S | 1 |
| Pucelikova, T | 1 |
| Dangas, G | 1 |
| Knoderer, CA | 1 |
| Leiser, JD | 1 |
| Nailescu, C | 1 |
| Turrentine, MW | 1 |
| Andreoli, SP | 1 |
| Roasio, A | 1 |
| Lobreglio, R | 1 |
| Santin, A | 1 |
| Marino, G | 1 |
| Fochi, O | 1 |
| Maj, G | 1 |
| Sheiban, I | 1 |
| Jones, DR | 1 |
| Lee, HT | 1 |
| Singer, I | 1 |
| Swan, SK | 1 |
| Lambrecht, LJ | 1 |
| Anjum, S | 1 |
| Fellmann, J | 1 |
| McGuire, D | 1 |
| Luther, RR | 1 |
| Aurora, RN | 1 |
| Milite, F | 1 |
| Carlon, G | 1 |
| Halpenny, M | 2 |
| Markos, F | 1 |
| Snow, HM | 1 |
| Duggan, PF | 1 |
| Gaffney, E | 1 |
| O'Connell, DP | 1 |
| Shorten, GD | 3 |
| Lakshmi, S | 1 |
| O'Donnell, A | 1 |
| O'Callaghan-Enright, S | 1 |
| Chu, VL | 1 |
| Cheng, JW | 1 |
| Wang, A | 1 |
| Stephens, CT | 1 |
| Jandhyala, BS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Fenoldopam in Reducing the Need for Renal Replacement Therapy After Cardiac Surgery. A Randomized Controlled Study.[NCT00621790] | Phase 3 | 667 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| Role of Mitochondrial Dysfunction in the Occurrence of Acute Kidney Injury(AKI) in Postoperative Cardiac Surgery[NCT04125069] | 27 participants (Actual) | Observational | 2019-10-02 | Completed | |||
| Impact of Intraoperative Hypotension on Risk of Acute Kidney Injury After Off-pump Coronary Artery Bypass Grafting Surgery: A Retrospective Cohort Study[NCT03889730] | 821 participants (Actual) | Observational | 2019-03-03 | Completed | |||
| Lithium in Cardiac Surgery Related Acute Kidney Injury: A Pilot Study[NCT03056248] | Phase 4 | 50 participants (Anticipated) | Interventional | 2017-04-01 | Not yet recruiting | ||
| Intraoperative Fenoldopam Infusion in Children Requiring Cardiopulmonary Bypass During Cardiac Surgery[NCT00982527] | Phase 3 | 80 participants (Actual) | Interventional | 2009-09-30 | Completed | ||
| Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
| Fenoldopam Prophylaxis of Splanchnic Organs Underperfusion During Cardiopulmonary Bypass: a Randomized, Controlled Trial.[NCT00747331] | Phase 4 | 80 participants (Anticipated) | Interventional | 2008-09-30 | Completed | ||
| Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial[NCT02981680] | 180 participants (Actual) | Interventional | 2013-11-30 | Completed | |||
| Clinical Controlled Trial to Determinate the Role of Sodium Bicarbonate in the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing to Diagnostic Coronariography and/or Percutaneous Coronary Intervention[NCT00424320] | Phase 3 | 100 participants | Interventional | 2006-10-31 | Recruiting | ||
| The Prevention Contrast-Induced Acute Kidney Injury With the Triple Combination of Hydration With Physiological Saline, N-Acetylcysteine and Sodium Bicarbonate[NCT01210456] | Phase 3 | 458 participants (Anticipated) | Interventional | 2009-10-31 | Enrolling by invitation | ||
| Pre-existing Microalbuminuria Predicting Contrast-induced Acute Kidney Injury (CIAKI) Following Coronary Angiography (CAG)[NCT02808845] | 800 participants (Anticipated) | Observational | 2016-12-31 | Not yet recruiting | |||
| Early Detection of Contrast Induced Nephropathy After Coronary Angiography : Predictive Value of Osteopontin[NCT05547581] | 155 participants (Anticipated) | Observational | 2022-12-07 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
36 reviews available for fenoldopam and Acute Kidney Failure
| Article | Year |
|---|---|
Does Fenoldopam Protect Kidney in Cardiac Surgery? A Systemic Review and Meta-Analysis With Trial Sequential Analysis.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Fenoldopam; Hospital Mortality; Humans; Kidney; Po | 2019 |
Fenoldopam Mesylate: A Narrative Review of Its Use in Acute Kidney Injury.
Topics: Acute Kidney Injury; Dopamine Agonists; Fenoldopam; Humans; Kidney; Male; Receptors, Dopamine D1; Tr | 2019 |
Update on clinical trials for the prevention of acute kidney injury in patients undergoing cardiac surgery.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Blood Glucose; Blood Tr | 2013 |
Therapeutic strategies to prevent contrast-induced acute kidney injury.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Calcium Channel Blockers; Contrast Media; Diureti | 2013 |
Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis.
Topics: Acute Kidney Injury; Fenoldopam; Hospital Mortality; Humans; Surgical Procedures, Operative | 2015 |
Acute kidney injury following cardiac surgery: current understanding and future directions.
Topics: Acute Kidney Injury; Antihypertensive Agents; Biomarkers; Cardiac Surgical Procedures; Creatinine; F | 2016 |
Prevention of acute kidney injury in Intensive Care Units.
Topics: Acute Kidney Injury; Contrast Media; Critical Care; Diuretics; Fenoldopam; Fluid Therapy; Hemodynami | 2017 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Fenoldopam; Humans; Renal Dialysis; Renal Insufficiency; Renal | 2008 |
Impaired blood flow in acute kidney injury: pathophysiology and potential efficacy of intrarenal vasodilator therapy.
Topics: Acute Kidney Injury; Catheterization; Fenoldopam; Humans; Renal Circulation; Vasodilator Agents | 2009 |
Preventing acute kidney injury after noncardiac surgery.
Topics: Acute Disease; Acute Kidney Injury; Atrial Natriuretic Factor; Cardiac Output; Fenoldopam; Hemodynam | 2010 |
Preventing acute kidney injury after cardiac surgery.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Coronary Artery Bypass, Off-Pump; Early Diagnosis; | 2011 |
Preventing acute kidney injury after cardiac surgery.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Coronary Artery Bypass, Off-Pump; Early Diagnosis; | 2011 |
Preventing acute kidney injury after cardiac surgery.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Coronary Artery Bypass, Off-Pump; Early Diagnosis; | 2011 |
Preventing acute kidney injury after cardiac surgery.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Coronary Artery Bypass, Off-Pump; Early Diagnosis; | 2011 |
Diuretics in acute kidney injury.
Topics: Acute Kidney Injury; Diuretics; Diuretics, Osmotic; Fenoldopam; Humans; Natriuretic Peptides; Sodium | 2011 |
Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Fenoldopam; Humans; Randomized Controlled Trials a | 2012 |
Preventable risk factors for acute kidney injury in patients undergoing cardiac surgery.
Topics: Acute Kidney Injury; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Asp | 2012 |
Contrast-induced nephropathy: protective role of fenoldopam.
Topics: Acute Kidney Injury; Animals; Clinical Trials as Topic; Contrast Media; Fenoldopam; Humans; Infusion | 2012 |
Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.
Topics: Acute Kidney Injury; Cardiovascular Diseases; Contrast Media; Coronary Angiography; Dopamine Agonist | 2001 |
Radiocontrast-induced acute renal failure: allocations and outcomes.
Topics: Acute Kidney Injury; Angiography; Contrast Media; Dopamine Agonists; Female; Fenoldopam; Humans; Kid | 2001 |
Radiocontrast nephropathy: the dye is not cast.
Topics: Acute Kidney Injury; Cardiac Catheterization; Contrast Media; Creatinine; Dopamine Agonists; Fenoldo | 2000 |
Prevention of radiocontrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Contrast Media; Creatinine; Fenoldopam; Hemofiltration | 2004 |
Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
Topics: Acute Kidney Injury; Contrast Media; Fenoldopam; Humans; Injections, Intravenous; Kidney; Radiopharm | 2004 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Calcium Channel Blockers; Diuretics; Dopamine; | 2003 |
Acute renal failure.
Topics: Acute Kidney Injury; Diuretics; Dopamine; Dopamine Agonists; Fenoldopam; Fluid Therapy; Humans; Mann | 2004 |
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atri | 2005 |
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atri | 2005 |
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atri | 2005 |
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atri | 2005 |
Contrast nephropathy.
Topics: Acute Kidney Injury; Angiography; Contrast Media; Fenoldopam; Humans; Incidence; Risk Factors | 2003 |
Acute renal failure.
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Amphotericin B; Calcium Channel Blockers; Diur | 2005 |
[Nephropathy caused by radiocontrast media].
Topics: Acetylcysteine; Acute Kidney Injury; Clinical Trials as Topic; Contrast Media; Fenoldopam; Fluid The | 2005 |
Renal failure (acute).
Topics: Acetylcysteine; Acute Kidney Injury; Aminoglycosides; Aminophylline; Amphotericin B; Calcium Channel | 2006 |
Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials.
Topics: Acute Kidney Injury; Critical Illness; Fenoldopam; Humans; Randomized Controlled Trials as Topic; Ri | 2007 |
Current literature questions the routine use of low-dose dopamine.
Topics: Acute Kidney Injury; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Fenoldopam; Humans | 2007 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; | 2008 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; | 2008 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; | 2008 |
Contrast-induced nephropathy.
Topics: Acetylcysteine; Acute Kidney Injury; Calcium Channel Blockers; Contrast Media; Coronary Angiography; | 2008 |
Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Case-Control Studies; Creatinine; Dopamine A | 2008 |
Perioperative renal protection.
Topics: Acute Kidney Injury; Anesthesiology; Biomarkers; Creatinine; Dopamine Agonists; Fenoldopam; Humans; | 2008 |
Potential of dopamine A-1 agonists in the management of acute renal failure.
Topics: Acute Kidney Injury; Animals; Dopamine; Fenoldopam; Humans; Receptors, Dopamine D1 | 1998 |
Will this magic bullet fly true?
Topics: Acute Kidney Injury; Dopamine Agonists; Fenoldopam; Humans | 2001 |
Fenoldopam in the prevention of contrast media-induced acute renal failure.
Topics: Acute Kidney Injury; Animals; Contrast Media; Dopamine Agonists; Fenoldopam; Humans; Renal Circulati | 2001 |
[Fenoldopam: potential clinical applications in heart surgery].
Topics: Acute Kidney Injury; Antihypertensive Agents; Coronary Artery Bypass; Diuretics; Dopamine Agonists; | 2001 |
13 trials available for fenoldopam and Acute Kidney Failure
| Article | Year |
|---|---|
Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Creatinine; Critical Illness; Double-Blind M | 2014 |
Fenoldopam in critically ill patients with early renal dysfunction. A crossover study.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; Cross-Over Studies; Dopamine Agonists; Double-Bl | 2011 |
High-dose fenoldopam reduces postoperative neutrophil gelatinase-associated lipocaline and cystatin C levels in pediatric cardiac surgery.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Biomarkers; Cardiac Surgical Procedures; Cystatin C; Doub | 2011 |
Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.
Topics: Acute Kidney Injury; Aged; Carcinoma, Renal Cell; Creatinine; Dopamine Agonists; Double-Blind Method | 2013 |
Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chi-Square Distributio | 2001 |
Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
Topics: Acute Kidney Injury; Adult; Aged; Contrast Media; Coronary Angiography; Dopamine Agonists; Dose-Resp | 2001 |
Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
Topics: Acute Kidney Injury; Aged; Biomarkers; Cardiac Surgical Procedures; Cohort Studies; Creatinine; Dopa | 2004 |
Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
Topics: Acute Kidney Injury; Aged; Biomarkers; Cardiac Surgical Procedures; Cohort Studies; Creatinine; Dopa | 2004 |
Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
Topics: Acute Kidney Injury; Aged; Biomarkers; Cardiac Surgical Procedures; Cohort Studies; Creatinine; Dopa | 2004 |
Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.
Topics: Acute Kidney Injury; Aged; Biomarkers; Cardiac Surgical Procedures; Cohort Studies; Creatinine; Dopa | 2004 |
Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Blood Volume; Cyclosporine; Diuretics; Dopami | 2004 |
Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial.
Topics: Acute Kidney Injury; Creatinine; Dopamine Agonists; Double-Blind Method; Female; Fenoldopam; Humans; | 2005 |
A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
Topics: Acute Kidney Injury; Aged; Critical Illness; Dopamine; Dopamine Agonists; Female; Fenoldopam; Humans | 2006 |
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.
Topics: Acute Kidney Injury; Adult; Analysis of Variance; Antihypertensive Agents; Blood Flow Velocity; Cros | 1999 |
Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting.
Topics: Acute Kidney Injury; Adult; Aged; Blood Pressure; Coronary Artery Bypass; Creatine; Dopamine Agonist | 2001 |
Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy.
Topics: Acute Kidney Injury; Adult; Contrast Media; Double-Blind Method; Female; Fenoldopam; Humans; Kidney; | 2002 |
29 other studies available for fenoldopam and Acute Kidney Failure
| Article | Year |
|---|---|
Effects of fenoldopam on kidney function parameters and its therapeutic efficacy in the management of acute kidney injury in dogs with heatstroke.
Topics: Acute Kidney Injury; Animals; Blood Pressure; Dog Diseases; Dogs; Dopamine Agonists; Female; Fenoldo | 2018 |
Prevention of acute kidney injury using vasoactive or antiplatelet treatment: three strikes and out?
Topics: Acute Kidney Injury; Adrenergic alpha-2 Receptor Agonists; Aspirin; Cardiac Surgical Procedures; Clo | 2014 |
Intravenous fenoldopam for early acute kidney injury after liver transplantation.
Topics: Acute Kidney Injury; Creatinine; Cystatin C; Female; Fenoldopam; Glomerular Filtration Rate; Humans; | 2015 |
[Fenoldopam in patients with acute kidney injury after cardiac surgery].
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Fenoldopam; Follow-Up Studies; Humans; Randomized | 2015 |
Intravenous fenoldopam for acute kidney injury.
Topics: Acute Kidney Injury; Female; Fenoldopam; Humans; Liver Transplantation; Male | 2015 |
Fenoldopam in cardiac surgery-associated acute kidney injury.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Aortic Diseases; Atherosclerosis; Blo | 2008 |
Invited commentary.
Topics: Acute Kidney Injury; Blood Flow Velocity; Cardiopulmonary Bypass; Coronary Artery Bypass; Dose-Respo | 2010 |
Direct infusion of fenoldopam into the renal arteries to protect against contrast-induced nephropathy in patients at increased risk.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Cohort Studies; Contrast Media; Dopamine Agonists; Fem | 2012 |
Editorial comment.
Topics: Acute Kidney Injury; Carcinoma, Renal Cell; Dopamine Agonists; Female; Fenoldopam; Glomerular Filtra | 2013 |
Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
Topics: Acute Kidney Injury; Aged; Case-Control Studies; Contrast Media; Coronary Angiography; Coronary Dise | 2001 |
The effects of intraoperative fenoldopam on renal blood flow and tubular function following suprarenal aortic cross-clamping.
Topics: Acute Kidney Injury; Animals; Aorta, Abdominal; Constriction; Creatinine; Dopamine Agonists; Fenoldo | 2003 |
Malignant hypertension presenting as hemolysis, thrombocytopenia, and renal failure.
Topics: Acute Kidney Injury; Adult; Antihypertensive Agents; Blood Chemical Analysis; Combined Modality Ther | 2003 |
[Fenoldopam and kidney function in a case of abdominal aortic pseudoaneurysm with supra-renal clamping in an emergency protocol].
Topics: Acute Kidney Injury; Aneurysm, False; Aorta, Abdominal; Aortic Rupture; Constriction; Dopamine Agoni | 2003 |
Acute renal failure after liver transplantation: the role of dopamine and fenoldopam.
Topics: Acute Kidney Injury; Dopamine; Dopamine Agents; Fenoldopam; Glomerular Filtration Rate; Humans; Live | 2004 |
Effect of fenoldopam mesylate in critically ill patients at risk for acute renal failure is dose dependent.
Topics: Acute Kidney Injury; Adult; Aged; Critical Illness; Dopamine Agonists; Dose-Response Relationship, D | 2005 |
Prophylactic fenoldopam for renal protection? No, thank you, not for me--not yet at least.
Topics: Acute Kidney Injury; Attitude of Health Personnel; Critical Care; Dopamine Agonists; Fenoldopam; Hum | 2005 |
Fluid balance in children after cardiac surgery: is fenoldopam an answer?
Topics: Acute Kidney Injury; Cardiopulmonary Bypass; Diuretics; Drug Therapy, Combination; Fenoldopam; Heart | 2006 |
Prevention of acute renal failure--first do no harm!
Topics: Acute Kidney Injury; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Diuretics; Diure | 2006 |
Selective renal arterial infusion of fenoldopam for the prevention of contrast-induced nephropathy.
Topics: Acute Kidney Injury; Catheterization; Contrast Media; Fenoldopam; Humans; Kidney Failure, Chronic; M | 2006 |
Fenoldopam: renal-dose dopamine redux?
Topics: Acute Kidney Injury; Critical Illness; Dopamine; Dopamine Agonists; Fenoldopam; Humans; Infusions, I | 2006 |
Fenoldopam inhibits nuclear translocation of nuclear factor kappa B in a rat model of surgical ischemic acute renal failure.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; DNA; Fenoldopam; Follow-Up Studies; Gene Expre | 2006 |
Use of fenoldopam to increase urine output in a patient with renal insufficiency secondary to septic shock: A case report.
Topics: Acute Kidney Injury; Adolescent; Diuretics; Fenoldopam; Humans; Intensive Care Units, Pediatric; Mal | 2006 |
Multifactorial acute renal failure treated with percutaneous targeted renal therapy (TRT): a case of "dialysis rescue".
Topics: Acute Kidney Injury; Administration, Cutaneous; Aged; Catheterization; Diabetic Nephropathies; Fenol | 2007 |
A probable case of nitroprusside intoxication.
Topics: Acute Kidney Injury; Blood Pressure; Fenoldopam; Humans; Intraoperative Complications; Male; Middle | 2007 |
Fenoldopam for acute kidney injury in children.
Topics: Acute Kidney Injury; Cardiomyopathies; Child; Dopamine Agonists; Female; Fenoldopam; Humans; Infant; | 2008 |
Fenoldopam reduces the incidence of renal replacement therapy after cardiac surgery.
Topics: Acute Kidney Injury; Aged; Cardiac Surgical Procedures; Case-Control Studies; Creatinine; Dopamine A | 2008 |
Preventing renal failure in critically ill patients.
Topics: Acute Kidney Injury; Critical Illness; Dopamine Agonists; Fenoldopam; Humans; Renal Circulation | 1999 |
Effects of prophylactic fenoldopam infusion on renal blood flow and renal tubular function during acute hypovolemia in anesthetized dogs.
Topics: Acute Kidney Injury; Analysis of Variance; Animals; Creatinine; Dogs; Female; Fenoldopam; Hemodynami | 2001 |
Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats.
Topics: Acute Kidney Injury; Animals; Disease Models, Animal; Dopamine Agonists; Fenoldopam; Glomerular Filt | 2002 |